semaglutide for the treatment of obesity Study reveals oral 50 mg as promising in adults: Lancet report FDA approves obesity drug that

These models enhance our understanding of how Chinese medicine exerts its effects and offer critical insights for novel drug development [241]

Natural compounds or TCM formulas with ferroptosis-inhibitory effects in other kidney diseases [e.g., berberine and irisflorentin (201, 202)] have not been tested in LN, representing an untapped therapeutic avenue

This is why personalized medical screening is essential

Subjects were then divided into 3 groups based on antidiabetic medication use: control patients (no use of GLP-1 analogs or SGLT-2 inhibitors), patients on GLP-1 analogs, and patients on SGLT-2 inhibitors

Endogenous GLP-1 is secreted by L-cells in the small intestine in response to food intake